All terms in GO

Label Id Description
negative regulation of ecdysone receptor signaling pathway GO_0120143 [Any process that stops, prevents, or reduces the frequency, rate or extent of any ecdysone receptor signaling pathway.]
regulation of ecdysone receptor signaling pathway GO_0120141 [Any process that modulates the frequency, rate or extent of the activity of any ecdysone receptor signaling pathway.]
positive regulation of ecdysone receptor signaling pathway GO_0120142 [Any process that activates or increases the frequency, rate or extent of any ecdysone receptor signaling pathway.]
negative regulation of testicular blood vessel morphogenesis GO_0061369 [Any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis in the testicle.]
obsolete negative regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity GO_0120140 [OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity.]
optic chiasma development GO_0061360 [The developmental process pertaining to the progression of the optic chiasm from its initial formation to the mature structure. The process begins when the pathfinding of the axons of the developing optic nerve cause some axons to cross at the midline of the brain and ends when the axons are mature.]
apoptotic process involved in luteolysis GO_0061364 [The apoptotic process that contributes to luteolysis.]
negative regulation of progesterone biosynthesis involved in luteolysis GO_0061363 [Any process that decreases the rate, frequency or extent of the biosynthesis of progesterone biosynthesis that contributes to luteolysis.]
negative regulation of maintenance of bipolar cell polarity regulating cell shape GO_0061362 [Any process that decreases the frequency, rate or extent of maintenance of bipolar cell polarity regulating cell shape.]
positive regulation of maintenance of bipolar cell polarity regulating cell shape GO_0061361 [Any process that increases the frequency, rate or extent of maintenance of bipolar cell polarity regulating cell shape.]
host cell peroxisome GO_0120149 [A small host cell organelle enclosed by a single membrane, and found in most eukaryotic cells. Contains peroxidases and other enzymes involved in a variety of metabolic processes including free radical detoxification, lipid catabolism and biosynthesis, and hydrogen peroxide metabolism.]
Lsm2-8 complex GO_0120115 [A heteroheptameric, nuclear protein complex composed of Lsm2, Lsm3, Lsm4, Lsm5, Lsm6, Lsm7, and Lsm8, or orthologs thereof, that selectively binds to snRNAs, in particular U6 or U6atac snRNAs, and also to unspliced transcripts localized within the nucleus.]
cytoplasm to vacuole targeting by the NVT pathway GO_0120113 [A pathway targeting soluble cytosolic proteins to the vacuole lumen. It uses a selective autophagy receptor protein Nbr1, which is an ortholog of mammalian NBR1, and is remotely related to S. cerevisiae Cvt pathway receptor protein Atg19. Similar to the Cvt pathway, the cargos transported by this pathway are hydrolases, which presumably contribute to the hydrolytic activities in the vacuole lumen. Different from the Cvt pathway, this pathway does not require the macroautophagy machinery, but instead relies on the ESCRT machinery for cargo sequestration. This pathway is observed in the fission yeast S. pombe.]
UDP-glucose transmembrane transport into endoplasmic reticulum GO_0120112 [The directed movement of UDP-glucose from cytosol to endoplasmic reticulum.]
interphase mitotic telomere clustering GO_0120110 [The process whereby the mitotic telomeres are gathered together during, or prior to, attachment to the nuclear envelope.]
obsolete canonical Wnt signaling pathway involved in metanephric kidney development GO_0061290 [OBSOLETE. The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes that contribute to the progression of the metanephric kidney over time. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.]
mesonephric renal vesicle induction GO_0061294 [Signaling at short range between cells of the ureteric bud terminus and the kidney mesenchyme that positively regulates the formation of the mesonephric renal vesicle.]
renal vesicle induction GO_0072034 [Signaling at short range between cells of the ureteric bud terminus and the kidney mesenchyme that positively regulates the formation of the renal vesicle.]
obsolete canonical Wnt signaling pathway involved in mesonephric nephron development GO_0061293 [OBSOLETE. The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes that contribute to the progression of the mesonephric nephron over time. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.]
obsolete canonical Wnt signaling pathway involved in mesonephros development GO_0061292 [OBSOLETE. The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes that contributes to the progression of the mesonephros over time. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.]